Search for: "IN RE WYETH"
Results 261 - 280
of 702
Sort by Relevance
|
Sort by Date
16 Sep 2011, 8:17 am
Ct. 2567 (2011), generic plaintiffs are picking through the wreckage much like we had to do after Wyeth v. [read post]
15 Sep 2011, 4:06 am
Wyeth. [read post]
14 Sep 2011, 12:08 pm
Rost was a Vice President, Marketing and Managing Director for Wyeth, responsible for the Nordic region in Europe.Dr. [read post]
14 Sep 2011, 12:08 pm
Rost was a Vice President, Marketing and Managing Director for Wyeth, responsible for the Nordic region in Europe.Dr. [read post]
14 Sep 2011, 12:07 pm
Rost was a Vice President, Marketing and Managing Director for Wyeth, responsible for the Nordic region in Europe.Dr. [read post]
14 Sep 2011, 12:07 pm
Rost was a Vice President, Marketing and Managing Director for Wyeth, responsible for the Nordic region in Europe.Dr. [read post]
14 Sep 2011, 9:04 am
PCN is scheduled to re-broadcast yesterday's oral arguments beginning at 11 a.m. eastern time today. [read post]
9 Sep 2011, 8:40 am
Rost was a Vice President, Marketing and Managing Director for Wyeth, responsible for the Nordic region in Europe.Dr. [read post]
2 Sep 2011, 1:44 pm
Wyeth v. [read post]
31 Aug 2011, 1:05 pm
John Classen got patents for immunizing mammals on a schedule, and determining whether there is an effect; patents which the patent office should have never allowed: 5,723,283; 6,420,139; & 6,638,739. [read post]
23 Aug 2011, 2:46 pm
” In re Morgan, 990 F.2d 1230, 1232 (Fed. [read post]
23 Aug 2011, 2:46 pm
In re Morgan, 990 F.2d 1230, 1232 (Fed. [read post]
17 Aug 2011, 5:00 am
Wyeth, 739 F. [read post]
11 Aug 2011, 1:09 pm
S ome of these we’re still fighting, but with the preemption threat to warning claims removed, most of these have receded into the background.We saw – and see – it a fourth time in PMA medical devices, especially after Riegel v. [read post]
5 Aug 2011, 9:38 am
Wyeth, 2011 U.S. [read post]
13 Jul 2011, 10:53 am
If a plaintiff argued that a defendant’s medical device should have been drastically re-designed to make it safer, would that purported state-law duty conflict with the terms of the device’s clearance? [read post]
13 Jul 2011, 3:04 am
(BIOtechNOW) US: PTO agrees to reexamine broad codon-optimization patents (Holman’s Biotech IP Blog) US: Inherently incomprehensible: Does the CAFC’s view of inherency in In Re Kao spell the end of second medical use patents in the USA? [read post]
12 Jul 2011, 7:47 am
In re Fosamax, 2011 U.S. [read post]
7 Jul 2011, 2:31 pm
You're looking for humility? [read post]
30 Jun 2011, 5:00 am
Wyeth Laboratories, 510 F. [read post]
